Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Gene B. Hubbard is active.

Publication


Featured researches published by Gene B. Hubbard.


Journal of Virology | 2004

Intrahepatic gene expression during chronic hepatitis C virus infection in chimpanzees

Catherine B. Bigger; Bernadette Guerra; Kathleen M. Brasky; Gene B. Hubbard; Michael R. Beard; Bruce A. Luxon; Stanley M. Lemon; Robert E. Lanford

ABSTRACT Hepatitis C virus (HCV) infections represent a global health problem and are a major contributor to end-stage liver disease including cirrhosis and hepatocellular carcinoma. An improved understanding of the parameters involved in disease progression is needed to develop better therapies and diagnostic markers of disease manifestation. To better understand the dynamics of host gene expression resulting from persistent virus infection, DNA microarray analyses were conducted on livers from 10 chimpanzees persistently infected with HCV. A total of 162 genes were differentially regulated in chronically infected animals compared to uninfected controls. Many genes exhibited a remarkable consistency in changes in expression in the 10 chronically infected animals. A second method of analysis identified 971 genes altered in expression during chronic infection at a 99% confidence level. As with acute-resolving HCV infections, many interferon (IFN)-stimulated genes (ISGs) were transcriptionally elevated, suggesting an ongoing response to IFN and/or double-stranded RNA which is amplified in downstream ISG expression. Thus, persistent infection with HCV results in a complex and partially predictable pattern of gene expression, although the underlying mechanisms regulating the different pathways are not well defined. A single genotype 3-infected animal was available for analysis, and this animal exhibited reduced levels of ISG expression compared to levels of expression with genotype 1 infections and increased expression of a number of genes potentially involved in steatosis. Gene expression data in concert with other observations from HCV infections permit speculation on the regulation of specific aspects of HCV infection.


Journals of Gerontology Series A-biological Sciences and Medical Sciences | 2009

Reduced Incidence and Delayed Occurrence of Fatal Neoplastic Diseases in Growth Hormone Receptor/Binding Protein Knockout Mice

Yuji Ikeno; Gene B. Hubbard; Shuko Lee; Lisa A. Cortez; Christie M. Lew; Celeste R. Webb; Darlene E. Berryman; Edward O. List; John J. Kopchick; Andrzej Bartke

Although studies of Ames and Snell dwarf mice have suggested possible important roles of the growth hormone (GH)/insulin-like growth factor-1 (IGF-1) axis in aging and age-related diseases, the results cannot rule out the possibility of other hormonal changes playing an important role in the life extension exhibited by these dwarf mice. Therefore, growth hormone receptor/binding protein (GHR/BP) knockout (KO) mice would be valuable animals to directly assess the roles of somatotropic axis in aging and age-related diseases because the primary hormonal change is due to GH/IGF-1 deficiency. Our pathological findings showed GHR/BP KO mice to have a lower incidence and delayed occurrence of fatal neoplastic lesions compared with their wild-type littermates. These changes of fatal neoplasms are similar to the effects observed with calorie restriction and therefore could possibly be a major contributing factor to the extended life span observed in the GHR/BP KO mice.


Journal of Virology | 2000

Cytokine Expression, Natural Killer Cell Activation, and Phenotypic Changes in Lymphoid Cells from Rhesus Macaques during Acute Infection with Pathogenic Simian Immunodeficiency Virus

Luis D. Giavedoni; M. Cristina Velasquillo; Laura M. Parodi; Gene B. Hubbard; Vida L. Hodara

ABSTRACT We studied the innate and adaptive immune system of rhesus macaques infected with the virulent simian immunodeficiency virus isolate SIVmac251 by evaluating natural killer (NK) cell activity, cytokine levels in plasma, humoral and virological parameters, and changes in the activation markers CD25 (interleukin 2R [IL-2R] α chain), CD69 (early activation marker), and CD154 (CD40 ligand) in lymphoid cells. We found that infection with SIVmac251 induced the sequential production of interferon-α/β (IFN-α/β), IL-18, and IL-12. IFN-γ, IL-4, and granulocyte-macrophage colony-stimulating factor were undetected in plasma by the assays used. NK cell activity peaked at 1 to 2 weeks postinfection and paralleled changes in viral loads. Maximum expression of CD69 on CD3−CD16+lymphocytes correlated with NK cytotoxicity during this period. CD25 expression, which is associated with proliferation, was static or slightly down-regulated in CD4+ T cells from both peripheral blood (PB) and lymph nodes (LN). CD69, which is normally present in LN CD4+ T cells and absent in peripheral blood leukocyte (PBL) CD4+ T cells, was down-regulated in LN CD4+ T cells and up-regulated in PBL CD4+ T cells immediately after infection. CD8+ T cells increased CD69 but not CD25 expression, indicating the activation of this cellular subset in PB and LN. Finally, CD154 was transiently up-regulated in PBL CD4+ T cells but not in LN CD4+ T cells. Levels of antibodies to SIV Gag and Env did not correlate with the level of activation of CD154, a critical costimulatory molecule for T-cell-dependent immunity. In summary, we present the first documented evidence that the innate immune system of rhesus macaques recognizes SIV infection by sequential production of proinflammatory cytokines and transient activation of NK cytotoxic activity. Additionally, pathogenic SIV induces drastic changes in the level of activation markers on T cells from different anatomic compartments. These changes involve activation in the absence of proliferation, indicating that activation-induced cell death may cause some of the reported increase in lymphocyte turnover during SIV infection.


Proceedings of the National Academy of Sciences of the United States of America | 2009

Pancreatic islet amyloidosis, β-cell apoptosis, and α-cell proliferation are determinants of islet remodeling in type-2 diabetic baboons

Rodolfo Guardado-Mendoza; Alberto M. Davalli; Alberto O. Chavez; Gene B. Hubbard; Edward J. Dick; Abraham Majluf-Cruz; Carlos Enrique Tene-Pérez; Lukasz Goldschmidt; John Hart; Carla Perego; Anthony G. Comuzzie; María Elizabeth Tejero; Giovanna Finzi; Claudia Placidi; Stefano La Rosa; Carlo Capella; Glenn A. Halff; Amalia Gastaldelli; Ralph A. DeFronzo; Franco Folli

β-Cell dysfunction is an important factor in the development of hyperglycemia of type-2 diabetes mellitus, and pancreatic islet amyloidosis (IA) has been postulated to be one of the main contributors to impaired insulin secretion. The aim of this study was to evaluate the correlation of IA with metabolic parameters and its effect on islets of Langerhans remodeling and relative endocrine-cell volume in baboons. We sequenced the amylin peptide, determined the fibrillogenic propensities, and evaluated pancreatic histology, clinical and biochemical characteristics, and endocrine cell proliferation and apoptosis in 150 baboons with different metabolic status. Amylin sequence in the baboon was 92% similar to humans and showed superimposable fibrillogenic propensities. IA severity correlated with fasting plasma glucose (FPG) (r = 0.662, P < 0.001) and HbA1c (r = 0.726, P < 0.001), as well as with free fatty acid, glucagon values, decreased homeostasis model assessment (HOMA) insulin resistance, and HOMA-B. IA severity was associated with a decreased relative β-cell volume, and increased relative α-cell volume and hyperglucagonemia. These results strongly support the concept that IA and β-cell apoptosis in concert with α-cell proliferation and hypertrophy are key determinants of islets of Langerhans “dysfunctional remodeling” and hyperglycemia in the baboon, a nonhuman primate model of type-2 diabetes mellitus. The most important determinants of IA were age and FPG (R2 = 0.519, P < 0.0001), and different FPG levels were sensitive and specific to predict IA severity. Finally, a predictive model for islet amyloid severity was generated with age and FPG as required variables.


Clinical and Vaccine Immunology | 2006

Detection of Anthrax Toxin in the Serum of Animals Infected with Bacillus anthracis by Using Engineered Immunoassays

Robert Mabry; Kathleen M. Brasky; Robert Geiger; Ricardo Carrion; Gene B. Hubbard; Stephen H. Leppla; Jean L. Patterson; George Georgiou; Brent L. Iverson

ABSTRACT Several strategies that target anthrax toxin are being developed as therapies for infection by Bacillus anthracis. Although the action of the tripartite anthrax toxin has been extensively studied in vitro, relatively little is known about the presence of toxins during an infection in vivo. We developed a series of sensitive sandwich enzyme-linked immunosorbent assays (ELISAs) for detection of both the protective antigen (PA) and lethal factor (LF) components of the anthrax exotoxin in serum. The assays utilize as capture agents an engineered high-affinity antibody to PA, a soluble form of the extracellular domain of the anthrax toxin receptor (ANTXR2/CMG2), or PA itself. Sandwich immunoassays were used to detect and quantify PA and LF in animals infected with the Ames or Vollum strains of anthrax spores. PA and LF were detected before and after signs of toxemia were observed, with increasing levels reported in the late stages of the infection. These results represent the detection of free PA and LF by ELISA in the systemic circulation of two animal models exposed to either of the two fully virulent strains of anthrax. Simple anthrax toxin detection ELISAs could prove useful in the evaluation of potential therapies and possibly as a clinical diagnostic to complement other strategies for the rapid identification of B. anthracis infection.


Aging Clinical and Experimental Research | 1997

Physical activity as a factor in the action of dietary restriction on aging: Effects in Fischer 344 rats

Roger McCarter; I. Shimokawa; Yuji Ikeno; Y. Higami; Gene B. Hubbard; Byung-Pal Yu; C. A. McMahan

Dietary restriction (DR) slows the rate of aging in laboratory rodents but the mechanism of action is unknown. DR is known to induce beneficial effects in a variety of tissues and organ systems. DR also maintains high levels of physical activity over the life span. We tested the hypothesis that lifelong physical activity is an important component of the anti-aging action of DR. Male specific pathogen-free Fischer 344 rats were divided into 4 groups at 6 weeks of age: A: fed ad libitum; AE: fed ad libitum and in cages with running wheels; B: fed 60% ad libitum; BE: fed 60% ad libitum and in cages with running wheels. Running activity and spontaneous cage activity were measured over 24 hours and over the life span. Metabolic rate was measured indirectly by analysis of air entering and leaving cages. AE rats exhibited low levels of running activity and ran very little beyond 6 months of age. In contrast, BE rats sustained high running levels even after all A and AE rats had died. High levels of wheel running did not decrease spontaneous cage activity. Median life span (50% survival) was in the order A = AE < B < BE. Ten percent survival was in the order A = AE < B = BE. BE rats had greatest median life span and also highest specific metabolic rate. Exercise and DR altered pathology: At death BE rats had a high incidence of cardiomyopathy, whereas A and AE rats had high incidence of chronic nephropathy and pituitary tumors. The data indicate that increased physical activity is probably not an important factor in the action of DR on aging.


Journal of Virology | 2005

A live attenuated vaccine for Lassa fever made by reassortment of Lassa and Mopeia viruses.

Igor S. Lukashevich; Jean L. Patterson; Ricardo Carrion; Dmitry Moshkoff; Anysha Ticer; Juan Carlos Zapata; Kathleen M. Brasky; Robert Geiger; Gene B. Hubbard; Joseph Bryant; Maria S. Salvato

ABSTRACT Lassa virus (LASV) and Mopeia virus (MOPV) are closely related Old World arenaviruses that can exchange genomic segments (reassort) during coinfection. Clone ML29, selected from a library of MOPV/LASV (MOP/LAS) reassortants, encodes the major antigens (nucleocapsid and glycoprotein) of LASV and the RNA polymerase and zinc-binding protein of MOPV. Replication of ML29 was attenuated in guinea pigs and nonhuman primates. In murine adoptive-transfer experiments, as little as 150 PFU of ML29 induced protective cell-mediated immunity. All strain 13 guinea pigs vaccinated with clone ML29 survived at least 70 days after LASV challenge without either disease signs or histological lesions. Rhesus macaques inoculated with clone ML29 developed primary virus-specific T cells capable of secreting gamma interferon in response to homologous MOP/LAS and heterologous MOPV and lymphocytic choriomeningitis virus. Detailed examination of two rhesus macaques infected with this MOPV/LAS reassortant revealed no histological lesions or disease signs. Thus, ML29 is a promising attenuated vaccine candidate for Lassa fever.


The Journal of Physiology | 2006

Effect of 30 per cent maternal nutrient restriction from 0.16 to 0.5 gestation on fetal baboon kidney gene expression

Laura A. Cox; Mark J. Nijland; Jeff Gilbert; Natalia E. Schlabritz-Loutsevitch; Gene B. Hubbard; Thomas J. McDonald; Robert E. Shade; Peter W. Nathanielsz

Despite variation in their protoplast organization and wall structure, monoraphid diatoms have traditionally been grouped as a single family or order, intermediate between the araphid and biraphid diatoms. However, the predominantly marine or brackish species of Achnanthes sensu stricto share protoplast and frustule features with representatives of the Mastogloiales rather than with other monoraphid diatoms. Meanwhile, studies of morphogenesis in Achnanthes have revealed that cells become monoraphid by filling in one raphe system during valve formation, indicating that the monoraphid condition is derived rather than primitive. Evidence from light and electron microscopy is presented to support the transfer of Achnanthes to the Mastogloiales, and an emended description of the order is given. It is concluded that the Achnanthales sensu Round et al. is a paraphyletic group and that the closest relatives of the various monoraphid genera must be sought among other raphid diatoms.


PLOS ONE | 2011

Does reduced IGF-1R signaling in Igf1r+/- mice alter aging?

Alex Bokov; Neha Garg; Yuji Ikeno; Sachin Thakur; Nicolas Musi; Ralph A. DeFronzo; Ning Zhang; Rebecca C. Erickson; Jonathan Gelfond; Gene B. Hubbard; Martin L. Adamo; Arlan Richardson

Mutations in insulin/IGF-1 signaling pathway have been shown to lead to increased longevity in various invertebrate models. Therefore, the effect of the haplo- insufficiency of the IGF-1 receptor (Igf1r+/−) on longevity/aging was evaluated in C57Bl/6 mice using rigorous criteria where lifespan and end-of-life pathology were measured under optimal husbandry conditions using large sample sizes. Igf1r+/− mice exhibited reductions in IGF-1 receptor levels and the activation of Akt by IGF-1, with no compensatory increases in serum IGF-1 or tissue IGF-1 mRNA levels, indicating that the Igf1r+/− mice show reduced IGF-1 signaling. Aged male, but not female Igf1r+/− mice were glucose intolerant, and both genders developed insulin resistance as they aged. Female, but not male Igf1r+/− mice survived longer than wild type mice after lethal paraquat and diquat exposure, and female Igf1r+/− mice also exhibited less diquat-induced liver damage. However, no significant difference between the lifespans of the male Igf1r+/− and wild type mice was observed; and the mean lifespan of the Igf1r+/− females was increased only slightly (less than 5%) compared to wild type mice. A comprehensive pathological analysis showed no significant difference in end-of-life pathological lesions between the Igf1r+/− and wild type mice. These data show that the Igf1r+/− mouse is not a model of increased longevity and delayed aging as predicted by invertebrate models with mutations in the insulin/IGF-1 signaling pathway.


Placenta | 2009

Feto-placental adaptations to maternal obesity in the baboon.

Darren Farley; María Elizabeth Tejero; Anthony G. Comuzzie; Paul B. Higgins; Laura A. Cox; Sherry Werner; Susan L. Jenkins; Cun Li; Jaehyek Choi; Edward J. Dick; Gene B. Hubbard; Patrice A. Frost; Donald Dudley; Brandon Ballesteros; Guoyao Wu; Peter W. Nathanielsz; Natalia E. Schlabritz-Loutsevitch

Maternal obesity is present in 20-34% of pregnant women and has been associated with both intrauterine growth restriction and large-for-gestational age fetuses. While fetal and placental functions have been extensively studied in the baboon, no data are available on the effect of maternal obesity on placental structure and function in this species. We hypothesize that maternal obesity in the baboon is associated with a maternal inflammatory state and induces structural and functional changes in the placenta. The major findings of this study were: 1) decreased placental syncytiotrophoblast amplification factor, intact syncytiotrophoblast endoplasmic reticulum structure and decreased system A placental amino acid transport in obese animals; 2) fetal serum amino acid composition and mononuclear cells (PBMC) transcriptome were different in fetuses from obese compared with non-obese animals; and 3) maternal obesity in humans and baboons is similar in regard to increased placental and adipose tissue macrophage infiltration, increased CD14 expression in maternal PBMC and maternal hyperleptinemia. In summary, these data demonstrate that in obese baboons in the absence of increased fetal weight, placental and fetal phenotype are consistent with those described for large-for-gestational age human fetuses.

Collaboration


Dive into the Gene B. Hubbard's collaboration.

Top Co-Authors

Avatar

Edward J. Dick

Texas Biomedical Research Institute

View shared research outputs
Top Co-Authors

Avatar

Natalia E. Schlabritz-Loutsevitch

University of Texas Health Science Center at San Antonio

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Yuji Ikeno

University of Texas Health Science Center at San Antonio

View shared research outputs
Top Co-Authors

Avatar

Natalia Schlabritz-Loutsevitch

Texas Tech University Health Sciences Center

View shared research outputs
Top Co-Authors

Avatar

John L. VandeBerg

Texas Biomedical Research Institute

View shared research outputs
Top Co-Authors

Avatar

M. Michelle Leland

University of Texas Health Science Center at San Antonio

View shared research outputs
Top Co-Authors

Avatar

Kathleen M. Brasky

Texas Biomedical Research Institute

View shared research outputs
Top Co-Authors

Avatar

Charleen M. Moore

University of Texas Health Science Center at San Antonio

View shared research outputs
Top Co-Authors

Avatar

Thomas J. McDonald

University of Texas Health Science Center at San Antonio

View shared research outputs
Researchain Logo
Decentralizing Knowledge